NIH-funded research P01 program project

Disruption of Transcription Networks in Esophageal Adenocarcinoma Tumorigenesis

Funded at University of Miami School of Medicine · NIH-11362544 · Data updated 2026-11-12

A research program at a major medical school is studying how certain gene networks and cellular processes contribute to the development of esophageal cancer in people with Barrett's esophagus and reflux.

More Adenocarcinoma research and trials

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionUniversity of Miami School of Medicine
NIH-funded
Lab location1 site (Coral Gables, United States)
Project startJuly 8, 2022
Project endJune 30, 2027
Funding year2026
Award (this year)$1,544,026
NIH project number5P01CA268991-05
Project IDNIH-11362544 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with Barrett's esophagus or GERD who could be candidates for future targeted therapies or participation in translational studies.

Less likely to help

Patients without esophageal cancer or Barrett's/esophageal pathology may not directly benefit from this program.

What this research studies

This project explores how specific transcription factors and protein modifications drive esophageal cancer in the context of reflux-related damage. It uses advanced animal models, 3-D cell systems, human tissues, and patient-derived samples to uncover mechanisms and test potential inhibitors. The work aims to translate findings into strategies to curb cancer cell survival and growth in the esophagus. Patients with Barrett’s esophagus or GERD may benefit from future therapies developed from these insights.

Why it matters

Potential benefit: If successful, it could lead to new treatments that target the transcription networks sustaining esophageal cancer.

How similar studies have gone: Prior work has shown that transcription factors and oxidative stress-related modifications can influence cancer progression, with ongoing advances in targeting these pathways.

Where this research is happening

  • University of Miami School of Medicine
    Coral Gables, United States
    Active

Researchers

  • Principal investigator: El-Rifai, Wael — University of Miami School of Medicine
  • Study coordinator: El-Rifai, Wael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.